Short description
Re-defining the way cardiovascular diseases are detected with Artificial Intelligence (AI)
Description
Idoven has developed the world’s first cardiology-as-a-service platform powered by artificial intelligence that augments both a cardiologist’s and non-cardiology expert clinician’s ability to identify, triage and diagnose patients at scale. The company counts partners such as AstraZeneca, Abbott, and GE Healthcare, FIFPRO, Google, Santander and Real Madrid Foundation. Idoven is backed by top-tier investors and business angels including Insight Partners, Northzone and Wayra (Telefónica), Iker Casillas, Pau Gasol, the Accel Starters program, and EIT Health. The company has been awarded with numerous distinctions for its AI technology in Europe and the US, including the prestigious European Innovation Council (EIC) Accelerator and Horizon 2020 (H2020) awards and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. CB Insights have also selected Idoven as one of the top 50 companies in Digital Health for 2023
Total funding
$$2020202
Sign in for full access
Location
Madrid, Madrid, Spain, Europe
Founded on
May 31, 2018
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Absolutely Noaccess, Noaccess, Cannot Access, No Way, Absolutely Noaccess, No Way, Nopepepe, Noaccessforu, Uh Ohhhh, Uh Ohhhh, Uh Ohhhh, Noway Youcantaccess, Cannot Access, Nopepepe, Absolutely Noaccess, No Way, Noway Youcantaccess, Uh Ohhhh, Absolutely Noaccess
Sign in for full access
Founders
Inigo Juantegui, José María Lillo Castellano, Manuel Marina Breysse